Reckitt Benckiser Stock Is Rebounding — But One Cost Shock Could Still Bite
Reckitt Benckiser shares rose 0.93% to 4,686p Thursday but remain down 7.61% over one month and 19.64% over three months. The company missed Q1 sales forecasts, posting 1.3% core growth versus 2.9% expected, and warned first-half margins will drop by about 200 basis points. Emerging markets grew 7.6%, while Europe fell 4.2%. Mead Johnson Nutrition remains up for sale.